@article{613754f834d7435881ff66e0edeaf5af,
title = "The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis",
abstract = "Rationale for a multinational registry Idiopathic pulmonary fibrosis (IPF) is the most prevalent of rare pulmonary diseases [1], and the most severe of the chronic forms of idiopathic interstitial pneumonias, with rising incidence and prevalence [2–4]. The prognosis for people diagnosed with IPF is a median survival of 3–3.5 years [1].",
keywords = "idiopathic pulmonary fibrosis, idiopathic pulmonary fibrosis",
author = "Vincent Cottin and Isabella Annesi-Maesano and Andreas G{\"u}nther and Liam Galvin and Michael Kreuter and Pippa Powell and Antje Prasse and George Reynolds and Luca Richeldi and Paolo Spagnolo and Claudia Valenzuela and Marlies Wijsenbeek and Wuyts, {Wim A.} and Bruno Crestani",
year = "2019",
doi = "10.1183/13993003.00539-2019",
language = "English",
volume = "53",
pages = "1--6",
journal = "European Respiratory Journal",
issn = "1399-3003",
publisher = "European Respiratory Society",
}